Antibodies: Impact Factor, Indexing, Publication Time & Fees


The Antibodies is reputed journal publishes research related to Drug Discovery (Q2); Immunology (Q2); Immunology and Allergy (Q2). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Antibodies: Details

Journal TitleAntibodies
PublisherMultidisciplinary Digital Publishing Institute (MDPI)
Publication CountrySwitzerland
ISSN20734468
Publication AreaImmunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics
Publication LanguageENG
Review ProcessAnonymous peer review
Scopus IndexedYes

Antibodies Impact Factor

The Impact Factor of Antibodies in 2026 is 3.3.

Journal Quartile

The Antibodies is ranked in Q3.

Indexing

The Antibodies is indexed in: DOAJ, Web of Science.

Publication Fee

There is a fee to publish in the Antibodies. The publication fee is 1800 CHF.

The journal also offers a fee waiver policy.

Publication Time

The Antibodies takes an average of 6 weeks to publish research papers.

Journal Official Website

The official website of the journal is http://www.mdpi.com/journal/antibodies.

Please visit only official website of the journal to submit research papers.



Similiar journals to publish


Antibodies
ISSN:
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Journal Scope: Drug Discovery (Q2); Immunology (Q2); Immunology and Allergy (Q2)

Human Antibodies
ISSN:
Publisher: SAGE Publications Ltd
Journal Scope: Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4)

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
ISSN:
Publisher: Mary Ann Liebert Inc.
Journal Scope: Immunology (Q4); Immunology and Allergy (Q4)

Human Antibodies and Hybridomas
ISSN: 0956960X
Publisher: Butterworth Scientific Ltd.
Journal Scope: